Metsera's experimental obesity drug showed significant weight loss and favorable tolerability in two mid-stage studies, the drug developer said on Monday. The injectable drug, MET-097i, led to a ...
Thousands of NHS patients are believed to be missing out. And with the NHS tightly restricting access, some working in the ...
Switching off a single enzyme in immune cells protected mice from obesity, type 2 diabetes, and fatty liver disease in a new ...
Five months after ending development of its own obesity treatment, Pfizer is accelerating its push into the rapidly growing ...
In the SIBAMATE study, more than 60% of patients lost at least 5% of body weight after 3 months of using ...
Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...
East Carroll Parish had the highest prevalence of obesity, while St. Tammany and Lafayette parishes had the lowest. How did ...
The study found that under permanent standard time, obesity would be reduced by 0.78% which equates to a reduction in 2.6 ...
Pfizer agreed to buy the obesity startup Metsera for an enterprise value of about $4.9 billion as it seeks to catch up in a ...
Childhood obesity in Indiana is rising, and the latest data show a challenge that is both urgent and complex. According to ...
The Desmond Tutu Health Foundation and the Department of Health have been honoured by the WHO for their innovative efforts in ...
Bulgaria ranks fifth in Europe for childhood obesity and sixth for adult obesity, costing the country about 9.2 billion euros (10.79 billion U.S. dollars), or 9.4 percent of GDP, in 2024, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback